ArticleBMC infectious diseases2016

Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.

Meredith Milstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.